Search Results - "Armario Hita, José Carlos"

Refine Results
  1. 1
  2. 2

    Bimekizumab: Short-Term Effectiveness and Safety in Real Clinical Practice in Andalucia, Spain by Ruiz-Villaverde, Ricardo, Rodriguez-Fernandez-Freire, Lourdes, Cebolla-Verdugo, Marta, Prados-Carmona, Alvaro, Hernández-Montoya, Carlos, Armario-Hita, José Carlos, Galán-Gutiérrez, Manuel

    Published in Life (Basel, Switzerland) (20-02-2024)
    “…: Psoriasis, a chronic inflammatory skin disease, affects 2-10% of the population globally. Bimekizumab (BMK), a monoclonal antibody targeting IL-17, is a dual…”
    Get full text
    Journal Article
  3. 3

    Matching-Adjusted Indirect Comparison of the Long-Term Efficacy Maintenance and Adverse Event Rates of Lebrikizumab versus Dupilumab in Moderate-to-Severe Atopic Dermatitis by Rand, Kim, Ramos-Goñi, Juan Manuel, Akmaz, Bülent, Solé-Feu, Laia, Armario-Hita, José-Carlos

    Published in Dermatology and therapy (01-01-2024)
    “…Introduction Lebrikizumab and dupilumab are monoclonal antibodies approved for treating moderate-to-severe atopic dermatitis (AD). Both have demonstrated…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11

    Upadacitinib for moderate to severe atopic dermatitis by Navarro-Triviño, Francisco, Alcantara-Luna, Sara, Domínguez-Cruz, Javier, Galán-Gutiérrez, Manuel, Ruiz-Villaverde, Ricardo, Pereyra-Rodriguez, José-Juan, Armario-Hita, José-Carlos

    Published in Immunotherapy (01-08-2023)
    “…Atopic dermatitis is an inflammatory skin disease, the prevalence of which has increased in the last decade. It affects all age groups, with adult involvement…”
    Get full text
    Journal Article
  12. 12

    Prevalence of chronic urticaria refractory to antihistamines in Andalucia, Spain by Pereyra‐Rodriguez, José Juan, Galán Gutiérrez, Manuel, ArmarioHita, José Carlos, Ruiz‐Villaverde, Ricardo

    Published in Dermatologic therapy (01-11-2020)
    “…Chronic urticaria (CU) has a devastating effect on the quality of life of patients who suffer from it. The objective of this study is to determine the…”
    Get full text
    Journal Article
  13. 13

    Mechanism, Diagnostic and Therapeutic Novelties in Dermatology: Where Are We Going? by Ruiz-Villaverde, Ricardo, Cebolla-Verdugo, Marta, Prados-Carmona, Alvaro, Pereyra Rodríguez, José Juan, Armario-Hita, José Carlos

    Published in Life (Basel, Switzerland) (01-10-2024)
    “…Dermatology is one of the oldest specialties and yet one of the most innovative and constantly evolving ones, too [...]…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Consensus on the Clinical Approach to Moderate-to-Severe Atopic Dermatitis in Spain: A Delphi Survey by Valero, Antonio, Silvestre, Juan Francisco, Martín-Santiago, Ana, Jáuregui, Ignacio, Herráez, L., Armario Hita, José Carlos, Baldrich, Esther Serra, Sastre, Joaquín, Ortiz de Frutos, Javier

    Published in Dermatology research and practice (2020)
    “…Background. The purpose of this study was to gather information on the current assessment and management of patients with moderate-to-severe AD in routine…”
    Get full text
    Journal Article
  20. 20

    Alternativa al cierre de heridas crónicas mediante injertos de Reverdin y factores de crecimiento en cirugía menor ambulatoria by Pérez Vega, Francisco Javier, Gutiérrez Vázquez, María Teresa, Lorenzo Peñuelas, José Ramón, Domínguez Bermúdez, Juan Francisco, Armario Hita, José Carlos, Castro Maqueda, Guillermo de

    Published in Gerokomos (01-03-2015)
    “…El cierre de heridas crónicas supone una alta tasa en cuidados de enfermería, sobre todo en heridas de difícil cicatrización, debido a la falta de respuesta a…”
    Get full text
    Journal Article